Electrocoreincis A Bioelectronic Medicine Company Based In Rockawaynew Jerseyfounded In 2005The Company Focuses On Non Invasive Vagus Nerve Stimulationnvnstherapies Aimed At Treating Neurological And Metabolic Conditionsit Reported $11 8 Million In Revenue In 2023 And Has A Team Of 73 Employees The Company S Key Products Include The Gammacore Sapphirea Handheld Device For Treating Migraine And Cluster Headachesand The Gammacorewhich Is Fda Cleared For Episodic Cluster Headache And Migraineadditionallyelectrocore Offers Truvaga 350 And Truvaga Pluswhich Are Designed For General Wellnessand Tac Stima Product For Human Performance Enhancementthe Nvns Platform Allows For Portable And Rechargeable Devices That Provide Electrical Stimulation To The Vagus Nerve Without The Need For Surgical Procedureselectrocore Is Actively Expanding Its Market Presence In The U Sand Internationallywhile Also Researching New Therapies For Conditions Such As Post Traumatic Headache And Long Covid Symptoms
